8-63065904-C-T

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong

The NM_000370.3(TTPA):​c.552G>A​(p.Thr184Thr) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

TTPA
NM_000370.3 splice_region, synonymous

Scores

2
Splicing: ADA: 0.9999
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 1.04
Variant links:
Genes affected
TTPA (HGNC:12404): (alpha tocopherol transfer protein) This gene encodes a soluble protein that binds alpha-trocopherol, a form of vitamin E, with high selectivity and affinity. This protein plays an important role in regulating vitamin E levels in the body by transporting vitamin E between membrane vesicles and facilitating the secretion of vitamin E from hepatocytes to circulating lipoproteins. Mutations in this gene cause hereditary vitamin E deficiency (ataxia with vitamin E deficiency, AVED) and retinitis pigmentosa. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. Scorers claiming Uncertain: max_spliceai. No scorers claiming Benign.
PP5
Variant 8-63065904-C-T is Pathogenic according to our data. Variant chr8-63065904-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 374211.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTPANM_000370.3 linkc.552G>A p.Thr184Thr splice_region_variant, synonymous_variant Exon 3 of 5 ENST00000260116.5 NP_000361.1 P49638

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTPAENST00000260116.5 linkc.552G>A p.Thr184Thr splice_region_variant, synonymous_variant Exon 3 of 5 1 NM_000370.3 ENSP00000260116.4 P49638
TTPAENST00000521138.1 linkn.233-17301G>A intron_variant Intron 1 of 1 5

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151994
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000199
AC:
5
AN:
251242
Hom.:
0
AF XY:
0.0000295
AC XY:
4
AN XY:
135790
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000137
AC:
20
AN:
1461562
Hom.:
0
Cov.:
30
AF XY:
0.0000179
AC XY:
13
AN XY:
727086
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000126
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152112
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74362
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000237
Hom.:
0
Bravo
AF:
0.0000113
EpiCase
AF:
0.0000546
EpiControl
AF:
0.00

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial isolated deficiency of vitamin E Pathogenic:5
May 17, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: TTPA c.552G>A (p.Thr184Thr) alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: One predicts the variant abolishes a 5' splicing donor site, two predict the variant weakens a 5' donor site, and two predict the variant creates a 3' acceptor site. At least two publications report experimental evidence that this variant affects mRNA splicing, producing a shortened mRNA transcript which lacks exon 3 (Tamaru_1997, Schuelke_1999). The mis-splicing is predicted to result in a shift in reading frame and a premature stop codon producing a truncated protein lacking the domains encoded by exons 3 to 5 (Schuelke_1999). The variant allele was found at a frequency of 2e-05 in 251242 control chromosomes. c.552G>A has been reported in the literature in individuals affected with Ataxia With Vitamin E Deficiency (Tamaru_1997, Schuelke_1999). These data indicate that the variant is likely to be associated with disease. Three clinical diagnostic laboratories and one research institution have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

Dec 08, 2016
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: research

- -

Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 28, 2019
Centogene AG - the Rare Disease Company
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 25, 2024
Baylor Genetics
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Pathogenic:2
Aug 13, 2022
Genetic Services Laboratory, University of Chicago
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

DNA sequence analysis of the TTPA gene demonstrated a sequence change, c.552G>A, in exon 3 that results in a synonymous amino acid change, p.Thr184Thr, in the apparent homozygous state. This sequence change occurs at the last base of exon 3 and in-silico splice prediction programs predict that this sequence change disrupts the canonical splice donor site at intron 3. RNA studies have demonstrated that this sequence change leads to the creation of an abnormal transcript lacking exon 3, and results in a premature stop codon (PMID: 9270601). This sequence change has been previously described in the homozygous state in individuals with ataxia with isolated vitamin E deficiency (PMID: 9270601, 9931538). This sequence change has been described in the gnomAD database in a total of 5 individuals, which corresponds to a frequency of 0.002% in the overall population (dbSNP rs181109321). Based on these collective evidences, this variant is considered likely pathogenic. -

Apr 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change affects codon 184 of the TTPA mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the TTPA protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs181109321, gnomAD 0.004%). This variant has been observed in individuals with TTPA-related conditions (PMID: 9270601, 9931538). ClinVar contains an entry for this variant (Variation ID: 374211). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in exon 3 skipping and introduces a premature termination codon (PMID: 9931538). The resulting mRNA is expected to undergo nonsense-mediated decay. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Ataxia, Friedreich-like, with isolated vitamin E deficiency Pathogenic:1
Feb 01, 1999
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
20
DANN
Benign
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.97
SpliceAI score (max)
0.43
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.43
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs181109321; hg19: chr8-63978463; API